Michael Groves’ journey from feeling healthy to facing a cancer diagnosis serves as a stark reminder of the need for earlier colorectal cancer screening. After experiencing abdominal pain in January 2021, Groves visited the emergency department, only to be told that appendicitis was not the cause. Shortly after, he noticed blood in his stool, prompting his family doctor to schedule a colonoscopy for April. The result? A shocking diagnosis of Stage 3 colorectal cancer, a five-centimetre tumour that had already spread to his lymph nodes.
A Shocking Diagnosis
Groves recalls, “The shock was just, like, wow, just devastating.” At the time, he was active and felt fit, even completing a 5K run just before his diagnosis. “I wasn’t tired. I was just a normal guy in his 40s,” he expressed. Following his diagnosis, he underwent surgery to remove a significant portion of his colon, followed by an arduous six-month chemotherapy regimen. The impact on his life was profound; he was unable to work for nearly nine months.
Now at 54, Groves is an advocate for change. He argues that had routine colorectal cancer screenings been available for those in their 40s, his tumour might have been detected earlier, significantly reducing the emotional and physical toll on his life.
Growing Concerns Over Colorectal Cancer Rates
The Canadian Cancer Society is echoing Groves’ sentiments, urging provincial and territorial governments to lower the standard screening age for colorectal cancer from 50 to 45. A concerning trend has emerged, with individuals under 50 experiencing colorectal cancer at alarming rates—two to 2.5 times more than in previous generations.
Brandon Purcell, advocacy manager for prevention and early detection at the Canadian Cancer Society, stated, “That growth is something that’s very concerning for us, and we think it’s time for governments to react to that so that we can catch more of these cancers early.”
Currently, routine screening involves a simple home-based fecal immunochemical test (FIT) for those aged 50 and older. If the test indicates blood, individuals are then referred for a colonoscopy. For those under 50 with risk factors, such as a family history or visible symptoms, proactive colonoscopies are already an option. However, advocates argue that expanding routine screening to include those aged 45 and above could lead to earlier detection and significantly improve survival rates.
The Evidence for Earlier Screening
The Canadian Cancer Society and Colorectal Cancer Canada have pointed to a recent modelling study published in the *Journal of the Canadian Association of Gastroenterology*. This research suggests that initiating home-based FIT at age 45 could prevent an estimated 15,070 cases of colorectal cancer and save approximately 6,100 lives over the next 45 years. Darren Brenner, a professor in oncology and community health sciences at the University of Calgary and senior author of the study, highlighted that the financial benefits could also be significant, projecting a savings of $233 million in cancer treatment costs—factoring in the expenses of additional screenings.
Moreover, the potential for colonoscopies to detect and remove precancerous polyps before they develop into cancer adds another layer of urgency. Barry Stein, president and CEO of Colorectal Cancer Canada, stressed that it takes eight to ten years for a polyp to progress to cancer, emphasising that earlier screening could make a substantial difference.
Why it Matters
The call to lower the colorectal cancer screening age is more than just a recommendation; it is a crucial step in a larger public health initiative. As rates of colorectal cancer rise among younger adults, timely intervention could mean the difference between life and death. By recognising the importance of early detection, healthcare authorities can not only enhance survival rates but also alleviate the emotional and financial burdens that come with late-stage diagnoses. It is imperative that policymakers heed the growing body of evidence and advocate for a proactive approach to colorectal cancer screening, ensuring that fewer individuals like Michael Groves face devastating diagnoses.
